Insights

Strategic Focus Early stage biotechnology startup developing EA-230 immunomodulatory peptide, indicating potential partnerships in clinical research, regulatory consulting, and specialized manufacturing services to support development and scale.

Funding Readiness Receives about $11M in funding with current revenue under $1M, suggesting opportunities for grant advisory, CRO alignment, and milestone-based service offerings to accelerate product milestones.

Small Team, Niche Headcount is 0-1, implying a high potential need for outsourced clinical operations, regulatory affairs support, and contract manufacturing to enable rapid progression without building in-house capabilities.

Digital Footprint Tech stack includes WordPress, Shopify, Azure, and Nginx, indicating receptivity to cloud-based solutions, cybersecurity services, and scalable e-commerce or marketing integrations for investor relations and partner outreach.

Clinical Focus Product EA-230 is an intravenously administered immunomodulatory peptide derived from a human pregnancy hormone, presenting opportunities in partnering with contract research organizations, specialty pharma players, and clinics focused on immunology and pregnancy-linked therapeutics.

Similar companies to Exponential Biotherapies, Inc.

Exponential Biotherapies, Inc. Tech Stack

Exponential Biotherapies, Inc. uses 8 technology products and services including WordPress, Shopify, Microsoft 365, and more. Explore Exponential Biotherapies, Inc.'s tech stack below.

Exponential Biotherapies, Inc.'s Email Address Formats

Exponential Biotherapies, Inc. uses at least 1 email format:
Exponential Biotherapies, Inc. Email FormatsExamplePercentage
First@exponential.orgJohn@exponential.org
100%

Frequently Asked Questions

What is Exponential Biotherapies, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Exponential Biotherapies, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Exponential Biotherapies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Exponential Biotherapies, Inc.'s official website is expobio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Exponential Biotherapies, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Exponential Biotherapies, Inc.'s annual revenue is estimated to be <$1M.

What is Exponential Biotherapies, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Exponential Biotherapies, Inc.'s SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 62 - Health Care and Social Assistance.

How many employees does Exponential Biotherapies, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Exponential Biotherapies, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include : G. H. Explore Exponential Biotherapies, Inc.'s employee directory with LeadIQ.

What industry does Exponential Biotherapies, Inc. belong to?

Minus sign iconPlus sign icon
Exponential Biotherapies, Inc. operates in the Hospitals and Health Care industry.

What technology does Exponential Biotherapies, Inc. use?

Minus sign iconPlus sign icon
Exponential Biotherapies, Inc.'s tech stack includes WordPress, Shopify, Microsoft 365, Google Fonts API, JSON-LD, Priority Hints, Microsoft Azure and Nginx.

What is Exponential Biotherapies, Inc.'s email format?

Minus sign iconPlus sign icon
Exponential Biotherapies, Inc.'s email format typically follows the pattern of First@exponential.org. Find more Exponential Biotherapies, Inc. email formats with LeadIQ.

How much funding has Exponential Biotherapies, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Exponential Biotherapies, Inc. has raised $11M in funding. The last funding round occurred on Jan 31, 2007 for $11M.
Exponential Biotherapies, Inc. logo

Exponential Biotherapies, Inc.

Hospitals and Health CareVirginia, United States0-1 Employees

Exponential Biotherapies, Inc. is a biotechnology company based in McLean, Virginia. The firm is developing EA-230, an intravenously administered peptide derived from a human pregnancy hormone and intended to modulate immune responses.

A September 2021 news item notes EA-230 as an active development program. The company is a small, U.S.-based organization focused on immunomodulatory therapies within the healthcare and biotechnology landscape. Its website is expobio.com for additional information.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
62 - Health Care and Social Assistance
Employees
0-1

Section iconFunding & Financials

  • $11M

    Exponential Biotherapies, Inc. has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Jan 31, 2007 in the amount of $11M as a Venture Round.

  • <$1M

    Exponential Biotherapies, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.